User profiles for Venkatesh L. Murthy

Venkatesh L. Murthy, MD, PhD

Associate Chief of Cardiology for Translational Research & Innovation, University of …
Verified email at umich.edu
Cited by 13655

Improved cardiac risk assessment with noninvasive measures of coronary flow reserve

VL Murthy, M Naya, CR Foster, J Hainer, M Gaber… - Circulation, 2011 - Am Heart Assoc
Background— Impaired vasodilator function is an early manifestation of coronary artery
disease and may precede angiographic stenosis. It is unknown whether noninvasive …

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis

…, M Naya, A Waller, CK Kim, VL Murthy… - Journal of the American …, 2014 - jacc.org
Objectives : This study sought to relate imaging findings on positron emission tomography (PET)
to adverse cardiac events in patients referred for evaluation of known or suspected …

Effects of sex on coronary microvascular dysfunction and cardiac outcomes

VL Murthy, M Naya, VR Taqueti, CR Foster, M Gaber… - Circulation, 2014 - Am Heart Assoc
Background— Coronary microvascular dysfunction (CMD) is a prevalent and prognostically
important finding in patients with symptoms suggestive of coronary artery disease. The …

Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus

VL Murthy, M Naya, CR Foster, M Gaber, J Hainer… - Circulation, 2012 - Am Heart Assoc
Background— Diabetes mellitus increases the risk of adverse cardiac outcomes and is
considered a coronary artery disease (CAD) equivalent. We examined whether coronary …

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …

…, G Merlini, EJ Miller, JC Moon, VL Murthy… - Journal of Nuclear …, 2019 - Springer
Cardiac amyloidosis is a form of restrictive infiltrative cardiomyopathy that confers significant
mortality. Due to the relative rarity of cardiac amyloidosis, clinical and diagnostic expertise …

Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early …

VR Taqueti, R Hachamovitch, VL Murthy, M Naya… - Circulation, 2015 - Am Heart Assoc
Background— Coronary flow reserve (CFR), an integrated measure of focal, diffuse, and
small-vessel coronary artery disease (CAD), identifies patients at risk for cardiac death. We …

Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events

…, QA Truong, M Steigner, VL Murthy… - Circulation …, 2014 - Am Heart Assoc
Background— The contribution of plaque extent to predict cardiovascular events among
patients with nonobstructive and obstructive coronary artery disease (CAD) is not well defined. …

Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study

RV Shah, VL Murthy, SA Abbasi, R Blankstein… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives : This study sought to evaluate differential effects of visceral fat (VF) and subcutaneous
fat and their effects on metabolic syndrome (MetS) risk across body mass index (BMI) …

Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis

C Gräni, C Eichhorn, L Bière, VL Murthy… - Journal of the American …, 2017 - jacc.org
Background : Diagnosing myocarditis is challenged by nonspecific clinical signs and
symptoms and low accuracy of endomyocardial biopsy. Cardiac magnetic resonance imaging (…

Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

…, W Chen, S Dorbala, EJ Miller, VL Murthy… - 2017 - Springer
Background Sarcoidosis is a systemic disease characterized by significant clinical heterogeneity.
Although most frequently involving the lungs, sarcoidosis may affect any organ. The …